WHO ICTRP trial
A prospective, randomized controlled study to compare clinical outcomes between…
KCT0005006 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0005006 |
|---|---|
| Public title | A prospective, randomized controlled study to compare clinical outcomes between bortezomib-melphalan-prednisolone and lenaldomide-dexamethasone in patients with transplant-ineligible, newly diagnosed multiple myeloma |
| Scientific title | A prospective, randomized controlled study to compare clinical outcomes between bortezomib-melphalan-prednisolone and lenaldomide-dexamethasone in patients with transplant-ineligible, newly diagnosed multiple myeloma |
| Primary sponsor | The Catholic University of Korea, Seoul St. Mary's Hospital |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Phase3 |
| Countries | Korea, Republic of |
| Conditions | Neoplasms |
| Interventions | Drug : All drugs for clinical trials administered in the VMP and RD groups are administered in the same manner as the protocol administered in the current Seoul St. Mary's Hospital and are applied and monitored according to the insurance… |
| Registration date | May 11, 2020 |
| Target size | 552 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: